290 related articles for article (PubMed ID: 9409318)
1. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318
[TBL] [Abstract][Full Text] [Related]
2. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension].
Zhang YL; Zhou SX; Lei J; Zhang JM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study.
Pankow JS; Arnett DK; Borecki IB; Hunt SC; Eckfeldt JH; Folsom AR; Djoussé L
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):551-8. PubMed ID: 10997795
[TBL] [Abstract][Full Text] [Related]
5. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
[TBL] [Abstract][Full Text] [Related]
11. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?
Panahloo A; Andrès C; Mohamed-Ali V; Gould MM; Talmud P; Humphries SE; Yudkin JS
Circulation; 1995 Dec; 92(12):3390-3. PubMed ID: 8521557
[TBL] [Abstract][Full Text] [Related]
12. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
13. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
[TBL] [Abstract][Full Text] [Related]
14. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.
Margaglione M; Cappucci G; d'Addedda M; Colaizzo D; Giuliani N; Vecchione G; Mascolo G; Grandone E; Di Minno G
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):562-7. PubMed ID: 9555861
[TBL] [Abstract][Full Text] [Related]
15. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
Velickovic J; Jelicic M; Stojkovic O
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
[TBL] [Abstract][Full Text] [Related]
16. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
17. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
Wong TY; Poon P; Szeto CC; Chan JC; Li PK
Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
[TBL] [Abstract][Full Text] [Related]
18. Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion/deletion polymorphism of the ACE gene.
Niemiec P; Zak I; Wita K
Genet Test; 2007; 11(4):353-9. PubMed ID: 18294050
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
[TBL] [Abstract][Full Text] [Related]
20. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
